Molecular Evidence Platform for Auditable, Continuous Optimization of Variant Interpretation in Genetic and Genomic Testing and Analysis
Copyright © Targeted News Service 2024
2024-11-05
ALEXANDRIA, Virginia, Nov. 5 -- LABORATORY CORPORATION OF AMERICA HOLDINGS, Burlington, North Carolina has been assigned a patent (No. US 12136472 B2, initially filed Sept. 14, 2023) developed by three inventors Alexandre Colavin, Menlo Park, California; Carlos L. Araya, Palo Alto, California; and Jason A. Reuter, Palo Alto, California, for "Molecular evidence platform for auditable, continuous optimization of variant interpretation in genetic and genomic testing and analysis." . . .